Tracking origins and spread of sulfadoxine-resistant Plasmodium falciparum dhps alleles in Thailand

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 1, 2011, Pages 155-164

  Alam, Md Tauqeer ^a,b   Vinayak, Sumiti ^a,b   Congpuong, Kanungnit ^c   Wongsrichanalai, Chansuda ^d   Satimai, Wichai ^c   Slutsker, Laurence ^a   Escalante, Ananias A ^e   Barnwell, John W ^a   Udhayakumar, Venkatachalam ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c MINISTRY OF PUBLIC HEALTH   (Thailand)

^d Independent Scholar   (Thailand)

^e ARIZONA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROPTEROATE SYNTHASE; MICROSATELLITE DNA; SULFADOXINE;

ANTIMALARIAL DRUG RESISTANCE; ARTICLE; CAMBODIA; DNA FLANKING REGION; GENE FREQUENCY; GENE LOCUS; GENE MUTATION; GENETIC VARIABILITY; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HETEROZYGOSITY; HUMAN; MYANMAR; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; THAILAND;

ALLELES; ANTIMALARIALS; DIHYDROPTEROATE SYNTHASE; DRUG RESISTANCE; GENOTYPE; MICROSATELLITE REPEATS; MUTATION; PHYLOGENY; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS; SULFADOXINE; THAILAND;

EID: 78650642051     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00691-10     Document Type: Article

References (55)

1. Anderson, T. J., and C. Roper. 2005. The origins and spread of antimalarial drug resistance: lessons for policy makers. Acta Trop. 94:269-280.
2. Babiker, H. A., I. M. Hastings, and G. Swedberg. 2009. Impaired fitness of drug-resistant malaria parasites: evidence and implication on drug-deployment policies. Expert Rev. Anti Infect. Ther. 7:581-593.
3. Biswas, S., A. Escalante, S. Chaiyaroj, P. Angkasekwinai, and A. A. Lal. 2000. Prevalence of point mutations in the dihydrofolate reductase and dihydropteroate synthetase genes of Plasmodium falciparum isolates from India and Thailand: a molecular epidemiologic study. Trop. Med. Int. Health 5:737-743.
4. Brooks, D. R., P. Wang, M. Read, W. M. Watkins, P. F. Sims, and J. E. Hyde. 1994. Sequence variation of the hydroxymethyldihydropterin pyrophosphokinase: dihydropteroate synthase gene in lines of the human malaria parasite, Plasmodium falciparum, with differing resistance to sulfadoxine. Eur. J. Biochem. 224:397-405.
5. Cavalli-Sforza, L. L., and A. W. Edwards. 1967. Phylogenetic analysis. Models and estimation procedures. Am. J. Hum. Genet. 19:233-257.
6. Chareonviriyaphap, T., M. J. Bangs, and S. Ratanatham. 2000. Status of malaria in Thailand. Southeast Asian J. Trop. Med. Public Health 31:225-237.
7. Chin, W., D. M. Bear, E. J. Colwell, and S. Kosakal. 1973. A comparative evaluation of sulfalene-trimethoprim and sulphormethoxine-pyrimethamine against falciparum malaria in Thailand. Am. J. Trop. Med. Hyg. 22:308-312.
8. Chongsuphajaisiddhi, T., and A. Sabchareon. 1981. Sulfadoxine- pyrimethamine resistant falciparum malaria in Thai children. Southeast Asian J. Trop. Med. Public Health 12:418-421. (Pubitemid 12139491)
9. Congpoung, K., J. P. Gil, P. Bualombai, Y. Kangchaingone, A. Darakapong, and W. H. Wernsdorfer. 2008. Mixed-species malaria infection in high transmission areas of Thailand. Asian Biomed. 2:117-121.
10. Dixon, K. E., R. G. Williams, T. Pongsupat, U. Pitaktong, and P. Phintuyothin. 1982. A comparative trial of mefloquine and Fansidar in the treatment of falciparum malaria: failure of Fansidar. Trans. R. Soc. Trop. Med. Hyg. 76:664-667.
11. Doberstyn, E. B., A. P. Hall, K. Vetvutanapibul, and P. Sonkon. 1976. Single-dose therapy of falciparum malaria using pyrimethamine in combination with diformyldapsone or sulfadoxine. Am. J. Trop. Med. Hyg. 25:14-19.
12. Doberstyn, E. B., P. Phintuyothin, S. Noeypatimanondh, and C. Teerakiartkamjorn. 1979. Single-dose therapy of falciparum malaria with mefloquine or pyrimethamine-sulfadoxine. Bull. World Health Organ. 57:275-279.
13. Dondorp, A. M., F. Nosten, P. Yi, D. Das, A. P. Phyo, J. Tarning, K. M. Lwin, F. Ariey, W. Hanpithakpong, S. J. Lee, P. Ringwald, K. Silamut, M. Imwong, K. Chotivanich, P. Lim, T. Herdman, S. S. An, S. Yeung, P. Singhasivanon, N. P. Day, N. Lindegardh, D. Socheat, and N. J. White. 2009. Artemisinin resistance in Plasmodium falciparum malaria. N. Engl. J. Med. 361:455-467.
14. Dondorp, A. M., S. Yeung, L. White, C. Nguon, N. P. Day, D. Socheat, and L. von Seidlein. 2010. Artemisinin resistance: current status and scenarios for containment. Nat. Rev. Microbiol. 8:272-280.
15. Escalante, A. A., D. L. Smith, and Y. Kim. 2009. The dynamics of mutations associated with anti-malarial drug resistance in Plasmodium falciparum. Trends Parasitol. 25:557-563.
16. Eyles, D. E., C. C. Hoo, M. Warren, and A. A. Sandosham. 1963. Plasmodium falciparum resistant to chloroquine in Cambodia. Am. J. Trop. Med. Hyg. 12:840-843.
17. Feil, E. J., B. C. Li, D. M. Aanensen, W. P. Hanage, and B. G. Spratt. 2004. eBURST: inferring patterns of evolutionary descent among clusters of related bacterial genotypes from multilocus sequence typing data. J. Bacteriol. 186:1518-1530.
18. Fidock, D. A., T. Nomura, A. K. Talley, R. A. Cooper, S. M. Dzekunov, M. T. Ferdig, L. M. Ursos, A. B. Sidhu, B. Naude, K. W. Deitsch, X. Z. Su, J. C. Wootton, P. D. Roepe, and T. E. Wellems. 2000. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol. Cell 6:861-871.
19. Gregson, A., and C. V. Plowe. 2005. Mechanisms of resistance of malaria parasites to antifolates. Pharmacol. Rev. 57:117-145.
20. Harinasuta, T., P. Suntharasamai, and C. Viravan. 1965. Chloroquineresistant falciparum malaria in Thailand. Lancet ii:657-660.
21. Hurwitz, E. S., D. Johnson, and C. C. Campbell. 1981. Resistance of Plasmodium falciparum malaria to sulfadoxine-pyrimethamine ('Fansidar') in a refugee camp in Thailand. Lancet i:1068-1070.
22. Isozumi, R., H. Uemura, D. D. Le, V. H. Truong, D. G. Nguyen, V. V. Ha, Q. P. Bui, V. T. Nguyen, and S. Nakazawa. 2010. Longitudinal survey of Plasmodium falciparum infection in Vietnam: characteristics of antimalarial resistance and their associated factors. J. Clin. Microbiol. 48:70-77.
23. Johnson, D. E., P. Roendej, and R. G. Williams. 1982. Falciparum malaria acquired in the area of the Thai-Khmer border resistant to treatment with Fansidar. Am. J. Trop. Med. Hyg. 31:907-912.
24. Jongwutiwes, S., C. Putaporntip, and A. L. Hughes. 2010. Bottleneck effects on vaccine-candidate antigen diversity of malaria parasites in Thailand. Vaccine 28:3112-3117.
25. Kublin, J. G., J. F. Cortese, E. M. Njunju, R. A. Mukadam, J. J. Wirima, P. N. Kazembe, A. A. Djimde, B. Kouriba, T. E. Taylor, and C. V. Plowe. 2003. Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi. J. Infect. Dis. 187:1870-1875.
26. Liu, K., and S. V. Muse. 2005. PowerMarker: an integrated analysis environment for genetic marker analysis. Bioinformatics 21:2128-2129.
27. Lozovsky, E. R., T. Chookajorn, K. M. Brown, M. Imwong, P. J. Shaw, S. Kamchonwongpaisan, D. E. Neafsey, D. M. Weinreich, and D. L. Hartl. 2009. Stepwise acquisition of pyrimethamine resistance in the malaria parasite. Proc. Natl. Acad. Sci. U. S. A. 106:12025-12030.
28. Mehlotra, R. K., H. Fujioka, P. D. Roepe, O. Janneh, L. M. Ursos, V. Jacobs-Lorena, D. T. McNamara, M. J. Bockarie, J. W. Kazura, D. E. Kyle, D. A. Fidock, and P. A. Zimmerman. 2001. Evolution of a unique Plasmodium falciparum chloroquine-resistance phenotype in association with pfcrt polymorphism in Papua New Guinea and South America. Proc. Natl. Acad. Sci. U. S. A. 98:12689-12694.
29. Mita, T. 2010. Origins and spread of pfdhfr mutant alleles in Plasmodium falciparum. Acta Trop. 114:166-170.
30. Na-Bangchang, K., and K. Congpuong. 2007. Current malaria status and distribution of drug resistance in East and Southeast Asia with special focus to Thailand. Tohoku J. Exp. Med. 211:99-113.
31. Nair, S., A. Brockman, L. Paiphun, F. Nosten, and T. J. Anderson. 2002. Rapid genotyping of loci involved in antifolate drug resistance in Plasmodium falciparum by primer extension. Int. J. Parasitol. 32:852-858.
32. Nair, S., J. T. Williams, A. Brockman, L. Paiphun, M. Mayxay, P. N. Newton, J. P. Guthmann, F. M. Smithuis, T. T. Hien, N. J. White, F. Nosten, and T. J. Anderson. 2003. A selective sweep driven by pyrimethamine treatment in Southeast Asian malaria parasites. Mol. Biol. Evol. 20:1526-1536.
33. Nash, D., S. Nair, M. Mayxay, P. N. Newton, J. P. Guthmann, F. Nosten, and T. J. Anderson. 2005. Selection strength and hitchhiking around two antimalarial resistance genes. Proc. Biol. Sci. 272:1153-1161.
34. Noedl, H., D. Socheat, and W. Satimai. 2009. Artemisinin-resistant malaria in Asia. N. Engl. J. Med. 361:540-541.
35. Park, S. D. E. 2001. Trypanotolerance in West African cattle and the population genetic effects of selection. Ph.D. thesis. University of Dublin, Dublin, Ireland.
36. Peterson, D. S., D. Walliker, and T. E. Wellems. 1988. Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria. Proc. Natl. Acad. Sci. U. S. A. 85:9114-9118.
37. Pinichpongse, S., E. B. Doberstyn, J. R. Cullen, L. Yisunsri, Y. Thongsombun, and K. Thimasarn. 1982. An evaluation of five regimens for the outpatient therapy of falciparum malaria in Thailand 1980-81. Bull. World Health Organ. 60:907-912.
38. Pumpaibool, T., C. Arnathau, P. Durand, N. Kanchanakhan, N. Siripoon, A. Suegorn, C. Sitthi-Amorn, F. Renaud, and P. Harnyuttanakorn. 2009. Genetic diversity and population structure of Plasmodium falciparum in Thailand, a low transmission country. Malar. J. 8:155.
39. Reeder, J. C., K. H. Rieckmann, B. Genton, K. Lorry, B. Wines, and A. F. Cowman. 1996. Point mutations in the dihydrofolate reductase and dihydropteroate synthetase genes and in vitro susceptibility to pyrimethamine and cycloguanil of Plasmodium falciparum isolates from Papua New Guinea. Am. J. Trop. Med. Hyg. 55:209-213.
40. Roper, C., R. Pearce, S. Nair, B. Sharp, F. Nosten, and T. Anderson. 2004. Intercontinental spread of pyrimethamine-resistant malaria. Science 305: 1124.
41. Segal, H. E., P. Chinvanthananond, B. Laixuthai, E. J. Pearlman, A. P. Hall, P. Phintuyothin, A. Na-Nakorn, and B. F. Castaneda. 1975. Comparison of diaminodiphenylsulphonepyrimethamine and sulfadoxine-pyrimethamine combinations in the treatment of falciparum malaria in Thailand. Trans. R. Soc. Trop. Med. Hyg. 69:139-142.
42. Triglia, T., and A. F. Cowman. 1994. Primary structure and expression of the dihydropteroate synthetase gene of Plasmodium falciparum. Proc. Natl. Acad. Sci. U. S. A. 91:7149-7153.
43. Triglia, T., J. G. Menting, C. Wilson, and A. F. Cowman. 1997. Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum. Proc. Natl. Acad. Sci. U. S. A. 94:13944-13949.
44. Triglia, T., P. Wang, P. F. Sims, J. E. Hyde, and A. F. Cowman. 1998. Allelic exchange at the endogenous genomic locus in Plasmodium falciparum proves the role of dihydropteroate synthase in sulfadoxine-resistant malaria. EMBO J. 17:3807-3815.
45. Verdrager, J. 1986. Epidemiology of the emergence and spread of drugresistant falciparum malaria in South-East Asia and Australasia. J. Trop. Med. Hyg. 89:277-289. (Pubitemid 17230038)
46. Vinayak, S., M. T. Alam, T. Mixson-Hayden, A. M. McCollum, R. Sem, N. K. Shah, P. Lim, S. Muth, W. O. Rogers, T. Fandeur, J. W. Barnwell, A. A. Escalante, C. Wongsrichanalai, F. Ariey, S. R. Meshnick, and V. Udhayakumar. 2010. Origin and evolution of sulfadoxine resistant Plasmodium falciparum. PLoS Pathog. 6:e1000830.
47. Wargo, A. R., S. Huijben, J. C. de Roode, J. Shepherd, and A. F. Read. 2007. Competitive release and facilitation of drug-resistant parasites after therapeutic chemotherapy in a rodent malaria model. Proc. Natl. Acad. Sci. U. S. A. 104:19914-19919.
48. White, N. J. 1992. Antimalarial drug resistance: the pace quickens. J. Antimicrob. Chemother. 30:571-585.
49. WHO Mekong Malaria Programme. 2008. Malaria in the greater Mekong subregion: regional and country profiles. WHO, Geneva, Switzerland. http: //www.whothailand.org/EN/Section3/Section113.htm.
50. Wongsrichanalai, C., A. L. Pickard, W. H. Wernsdorfer, and S. R. Meshnick. 2002. Epidemiology of drug-resistant malaria. Lancet Infect. Dis. 2:209-218.
51. Wongsrichanalai, C., J. Sirichaisinthop, J. J. Karwacki, K. Congpuong, R. S. Miller, L. Pang, and K. Thimasarn. 2001. Drug resistant malaria on the Thai-Myanmar and Thai-Cambodian borders. Southeast Asian J. Trop. Med. Public Health 32:41-49.
52. Wootton, J. C., X. Feng, M. T. Ferdig, R. A. Cooper, J. Mu, D. I. Baruch, A. J. Magill, and X. Z. Su. 2002. Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum. Nature 418:320-323.
53. Young, M. D., P. G. Contacos, J. E. Stitcher, and J. W. Millar. 1963. Drug resistance in Plasmodium falciparum from Thailand. Am. J. Trop. Med. Hyg. 12:305-314.
54. Zhou, G., J. Sirichaisinthop, J. Sattabongkot, J. Jones, O. N. Bjornstad, G. Yan, and L. Cui. 2005. Spatio-temporal distribution of Plasmodium falciparum and P. vivax malaria in Thailand. Am. J. Trop. Med. Hyg. 72:256-262.
55. Zhou, Z., S. M. Griffing, A. M. de Oliveira, A. M. McCollum, W. M. Quezada, N. Arrospide, A. A. Escalante, and V. Udhayakumar. 2008. Decline in sulfadoxine-pyrimethamine-resistant alleles after change in drug policy in the Amazon region of Peru. Antimicrob. Agents Chemother. 52:739-741.